Evidence map›Paper›PMID 39090331›Full record

ArticleScientific reports2024

Development of a noninvasive olfactory stimulation fMRI system in marmosets.

Terumi Yurimoto, Fumiko Seki, Akihiro Yamada, Junnosuke Okajima, Tomoyuki Yambe, Yoshiaki Takewa, Michiko Kamioka, Takashi Inoue, Yusuke Inoue, Erika Sasaki

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Terumi YurimotoDepartment of Marmoset Biology and Medicine, Central Institute for Experimental Medicine and Life Science, Kawasaki, Japan.
Fumiko SekiBioimaging Center, Central Institute for Experimental Medicine and Life Science, Kawasaki, Japan.
Akihiro YamadaDepartment of Clinical Engineering, Komatsu University, Komatsu, Japan.
Junnosuke OkajimaInstitute of Fluid Science, Tohoku University, Sendai, Japan.
Tomoyuki YambeInstitute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Yoshiaki TakewaAdvanced Medical Engineering Research Center, Asahikawa Medical University, Asahikawa, Japan.
Michiko KamiokaDepartment of Marmoset Biology and Medicine, Central Institute for Experimental Medicine and Life Science, Kawasaki, Japan.
Takashi InoueDepartment of Marmoset Biology and Medicine, Central Institute for Experimental Medicine and Life Science, Kawasaki, Japan.
Yusuke InoueInstitute of Development, Aging and Cancer, Tohoku University, Sendai, Japan. inoue@asahikawa-med.ac.jp.
Erika SasakiDepartment of Marmoset Biology and Medicine, Central Institute for Experimental Medicine and Life Science, Kawasaki, Japan. esasaki@ciea.or.jp.

Funding

Brain/MINDS JP19dm0207065JSPS KAKENHI JP20K16908
6 · The paper itself

Abstract

Olfactory dysfunction is associated with aging and the earliest stages of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases; it is thought to be an early biomarker of cognitive decline. In marmosets, a small non-human primate model used in brain research, olfactory pathway activity during olfactory stimulation has not been well studied because of the difficulty in clearly switching olfactory stimuli inside a narrow MRI. Here, we developed an olfactory-stimulated fMRI system using a small-aperture MRI machine. The olfactory presentation system consisted of two tubes, one for supply and one for suction of olfactory stimulants and a balloon valve. A balloon valve installed in the air supply tube controlled the presentation of the olfactory stimulant, which enabled sharp olfactory stimulation within MRI, such as 30 s of stimulation repeated five times at five-minute intervals. The olfactory stimulation system was validated in vivo and in a simulated system. fMRI analysis showed a rapid increase in signal values within 30 s of olfactory stimulation in eight regions related to the sense of smell. As these regions include those associated with Alzheimer's and Parkinson's diseases, olfactory stimulation fMRI may be useful in clarifying the relationship between olfactory dysfunction and dementia in non-human primates.

Indexed as

CallithrixMagnetic Resonance ImagingOlfaction DisordersAgingAnimalsMaleModels, AnimalSmell

Identifiers

PMID39090331
PMCPMC11294473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.